July 17, 2014

Purdue Pharma announced that the Food and Drug Administration approved a new 7.5-mcg/hour dosage strength of Butrans (buprenorphine) transdermal system CIII.

June 30, 2014

Actavis on Monday confirmed that it has filed an abbreviated new drug application with the Food and Drug Administration to market buprenorphine hydrochloride and naloxone hydrochloride dihydrate sublingual tablets.

June 17, 2014

As the heroin and opioid epidemic spreads through communities across the United States, Sens. Carl Levin, D-Mich., and Orrin Hatch, R-Utah, will hold a forum on Wednesday to discuss opioid addiction, focusing on the use of buprenorphine to help combat opioid abuse and the obstacles that have prevented even more patients from getting buprenorphine treatment. 


June 9, 2014

BioDelivery Sciences International on Monday announced that the Food and Drug Administration approved its new drug application for Bunavail (buprenorphine and naloxone) buccal film (CIII).

October 15, 2013

Actavis is hoping to become the first to market a generic version of a drug used to treat patients who have become dependent on opioid drugs, triggering a lawsuit from the branded drug's manufacturer.

September 24, 2013

The Food and Drug Administration has approved a new dosage strength for a chronic pain patch made by Purdue Pharma, the drug maker said Tuesday.

September 16, 2013

A drug for treating opioid dependence has been launched, the manufacturer said Monday.

July 9, 2013

The Food and Drug Administration has approved a new drug for treating opioid dependence.

June 11, 2013

Misperceptions and stereotypes about opioid dependence that may affect how it's treated have persisted among the general public and physicians despite increased attention devoted to the issue, according to a new survey.

March 26, 2013

The Food and Drug Administration has approved a drug for opioid dependence made by Actavis, the company said.

March 5, 2013

Amneal Pharmaceuticals has started shipping a drug used to treat opioid dependence, the company said Tuesday.

February 25, 2013

Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a drug to treat opioid dependence.

August 21, 2012

The Food and Drug Administration has approved a drug made by Reckitt Benckiser Pharmaceuticals for treating addiction to opioid drugs, the drug maker said.

December 13, 2011

A new law in Washington state intended to curb accidental deaths related to opioid painkillers is having some adverse side effects, according to published reports.

July 26, 2011

Second-quarter net revenue increased to 2.34 billion pounds ($3.83 billion) for Reckitt Benckiser, the company announced in an earnings statement Monday.

April 20, 2011

The Obama administration is looking to curb the growing national epidemic of prescription painkiller abuse, according to a plan unveiled Tuesday.

September 26, 2010

Hi-Tech Pharmacal will market a generic version of a drug used to treat opioid dependence,...

September 1, 2010

The Food and Drug Administration has approved Reckitt Benckiser’s treatment for opioid addiction, Reckitt Benckiser...

July 5, 2010

Purdue Pharma has received approval from the Food and Drug Administration for its analgesic product...